{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T22:39:43Z","timestamp":1774132783992,"version":"3.50.1"},"reference-count":50,"publisher":"American Veterinary Medical Association (AVMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>To describe mexiletine\u2019s efficacy in suppressing ventricular arrhythmias (VAs) and its safety in dogs.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>In a multicenter retrospective study, dogs received oral mexiletine, prescribed as a second-line antiarrhythmic in addition to a first-line agent, for the treatment of VA ineffectively controlled by initial monotherapy. Signalment, clinical, diagnostic, therapeutic, and outcome data were retrieved. Only dogs that underwent Holter monitoring both before and after starting mexiletine treatment were included in the ECG analysis of efficacy. This was represented by a reduction in the Lown-Wolf grade &lt; 5 or a reduction in the number of ventricular premature complexes \u2265 85%. Treatment-related side effects (TRSE) were noted in all dogs. Statistical analysis was performed to compare selected data before and after mexiletine prescription.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>38 dogs were included. Twenty dogs met the criteria for the efficacy analysis; mexiletine effectively suppressed VA in 16 of 20 cases (80%). In 11 of 38 dogs (28.9%), TRSE occurred (ie, gastrointestinal and neurological signs in 10 of 11 [90.9%] and 1 of 11 cases [9.1%], respectively). Supportive therapies were prescribed to 10 of 11 dogs (90.9%) and the daily dose of mexiletine was reduced in 6 of 11 dogs (54.5%), resulting in resolution of TRSE in 5 of 11 dogs (45.5%). In the remaining 6 of 11 dogs (54.5%), the persistence of TRSE led to the discontinuation of mexiletine. The median duration of TRSE was 7 days (IQR, 4 to 10 days).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Mexiletine was highly effective in suppressing VA, but reversible gastrointestinal TRSE occurred relatively frequently.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Clinical Relevance<\/jats:title>\n<jats:p>Useful information on the effects of mexiletine in dogs with VAs is provided.<\/jats:p>\n<\/jats:sec>","DOI":"10.2460\/javma.25.02.0088","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T08:25:49Z","timestamp":1750062349000},"page":"1-9","source":"Crossref","is-referenced-by-count":3,"title":["Antiarrhythmic efficacy and safety of oral mexiletine in dogs with ventricular arrhythmias: a multicentre, retrospective analysis"],"prefix":"10.2460","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3927-1601","authenticated-orcid":true,"given":"Giovanni","family":"Romito","sequence":"first","affiliation":[{"name":"Department of Veterinary Medical Sciences, Alma Mater Studiorum\u2014University of Bologna, Ozzano dell\u2019Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Mazzoldi","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Sciences, Alma Mater Studiorum\u2014University of Bologna, Ozzano dell\u2019Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Travaglini","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medical Sciences, Alma Mater Studiorum\u2014University of Bologna, Ozzano dell\u2019Emilia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Paradies","sequence":"additional","affiliation":[{"name":"Department of Precision and Regenerative Medicine and Ionian Area, Section of Veterinary Clinics, University of Bari, Valenzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Recchia","sequence":"additional","affiliation":[{"name":"Department of Precision and Regenerative Medicine and Ionian Area, Section of Veterinary Clinics, University of Bari, Valenzano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prisca","family":"Castagna","sequence":"additional","affiliation":[{"name":"Freelance veterinary cardiologist, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazzareno Giuseppe","family":"Pelle","sequence":"additional","affiliation":[{"name":"Freelance veterinary cardiologist, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlotta","family":"Valente","sequence":"additional","affiliation":[{"name":"Department of Animal Medicine, Production and Health, University of Padova, Legnaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Poser","sequence":"additional","affiliation":[{"name":"Department of Animal Medicine, Production and Health, University of Padova, Legnaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Guglielmini","sequence":"additional","affiliation":[{"name":"Department of Animal Medicine, Production and Health, University of Padova, Legnaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1272","reference":[{"issue":"1","key":"ref1","series-title":"Ann N Y Acad Sci","first-page":"224","article-title":"Spontaneous arrhythmias and conduction disturbances in domestic animals","volume":"127","author":"Buchanan JW","year":"1965","unstructured":"Buchanan JW. Spontaneous arrhythmias and conduction disturbances in domestic animals. Ann N Y Acad Sci. 1965;127(1):224-238. doi:10.1111\/j.1749-6632.1965.tb49405.x"},{"key":"ref2","series-title":"Kirk\u2019s Current Veterinary Therapy. Vol 15","first-page":"745","article-title":"Ventricular arrhythmias in dogs","author":"Oyama MA","year":"2014","unstructured":"Oyama MA, Reynolds CA. Ventricular arrhythmias in dogs. In: Bonagura JD, Twedt DC, eds. Kirk\u2019s Current Veterinary Therapy. Vol 15. Elsevier Saunders; 2014:745-748."},{"issue":"1","key":"ref3","series-title":"J Vet Res (Pulawy)","first-page":"103","article-title":"Prevalence of arrhythmias in dogs examined between 2008 and 2014","volume":"61","author":"Noszczyk-Nowak A","year":"2017","unstructured":"Noszczyk-Nowak A, Micha\u0142ek M, Ka\u0142u\u017ca E, Cepiel A, Pas\u0142awska U. Prevalence of arrhythmias in dogs examined between 2008 and 2014. J Vet Res (Pulawy). 2017;61(1):103-110. doi:10.1515\/jvetres-2017-0013"},{"issue":"1","key":"ref4","series-title":"Vet Rec Open","first-page":"e35","article-title":"Diagnosis and management of arrhythmias in dogs: a cross-sectional online survey among Flemish veterinary practitioners","volume":"9","author":"Hellemans A","year":"2022","unstructured":"Hellemans A, Schittekatte M, Covents M, Smets P. Diagnosis and management of arrhythmias in dogs: a cross-sectional online survey among Flemish veterinary practitioners. Vet Rec Open. 2022;9(1):e35. doi:10.1002\/vro2.35"},{"issue":"4","key":"ref5","series-title":"J Am Vet Med Assoc","first-page":"522","article-title":"Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers","volume":"221","author":"Meurs KM","year":"2002","unstructured":"Meurs KM, Spier AW, Wright NA,  Comparison of the effects of four antiarrhythmic treatments for familial ventricular arrhythmias in Boxers. J Am Vet Med Assoc. 2002;221(4):522-527. doi:10.2460\/javma.2002.221.522"},{"issue":"1","key":"ref6","series-title":"J Vet Intern Med","first-page":"1","article-title":"Toxicity in Doberman Pinchers with ventricular arrhythmias treated with amiodarone (1996-2005)","volume":"23","author":"Kraus MS","year":"2009","unstructured":"Kraus MS, Thomason JD, Fallaw TL, Calvert CA. Toxicity in Doberman Pinchers with ventricular arrhythmias treated with amiodarone (1996-2005). J Vet Intern Med. 2009;23(1):1-6. doi:10.1111\/j.1939-1676.2008.0227.x"},{"issue":"2","key":"ref7","series-title":"J Vet Cardiol","first-page":"93","article-title":"Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German Shepherd Dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study","volume":"12","author":"Gelzer AR","year":"2010","unstructured":"Gelzer AR, Kraus MS, Rishniw M, Hemsley SA, Mo\u00efse NS. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German Shepherd Dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study. J Vet Cardiol. 2010;12(2):93-106. doi:10.1016\/j.jvc.2010.06.001"},{"issue":"1","key":"ref8","series-title":"J Small Anim Pract","first-page":"19","article-title":"Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010)","volume":"53","author":"Pedro B","year":"2012","unstructured":"Pedro B, L\u00f3pez-Alvarez J, Fonfara S, Stephenson H, Dukes-McEwan J. Retrospective evaluation of the use of amiodarone in dogs with arrhythmias (from 2003 to 2010). J Small Anim Pract. 2012;53(1):19-26. doi:10.1111\/j.1748-5827.2011.01142.x"},{"issue":"10","key":"ref9","series-title":"Vet Rec","first-page":"268","article-title":"Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: a retrospective study of survival","volume":"172","author":"Caro-Vadillo A","year":"2013","unstructured":"Caro-Vadillo A, Garc\u00eda-Guasch L, Carret\u00f3n E, Montoya-Alonso JA, Manubens J. Arrhythmogenic right ventricular cardiomyopathy in Boxer dogs: a retrospective study of survival. Vet Rec. 2013;172(10):268. doi:10.1136\/vr.100937"},{"key":"ref10","series-title":"J Vet Cardiol","first-page":"20","article-title":"Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases","volume":"53","author":"Romito G","year":"2024","unstructured":"Romito G, Gemma N, Dondi F, Mazzoldi C, Fasoli S, Cipone M. Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases. J Vet Cardiol. 2024;53:20-35. doi:10.1016\/j.jvc.2024.03.002"},{"key":"ref11","series-title":"Drugs for the Heart","first-page":"272","article-title":"Antiarrhythmic drugs and strategies","author":"Nattel S","year":"2013","unstructured":"Nattel S, Gersh BJ, Opie LH. Antiarrhythmic drugs and strategies. In: Opie LH, Gersh BJ, eds. Drugs for the Heart. 8th ed. Elsevier Saunders; 2013:272-331. doi:10.1016\/B978-1-4557-3322-4.00017-X"},{"issue":"11","key":"ref12","series-title":"Europace","first-page":"1809","article-title":"Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review","volume":"24","author":"van der Ree MH","year":"2022","unstructured":"van der Ree MH, van Dussen L, Rosenberg N,  Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review. Europace. 2022;24(11):1809-1823. doi:10.1093\/europace\/euac087"},{"key":"ref13","series-title":"J Am Anim Hosp Assoc","first-page":"597","article-title":"Mexiletine administration for management of ventricular arrhythmias in 22 dogs","volume":"27","author":"Lunney J","year":"1991","unstructured":"Lunney J, Ettinger SJ. Mexiletine administration for management of ventricular arrhythmias in 22 dogs. J Am Anim Hosp Assoc. 1991;27:597-600."},{"key":"ref14","series-title":"Veterinaria","first-page":"19","article-title":"Esperienze cliniche sull\u2019utilizzo della mexiletine nel trattamento delle aritmie ventricolari nel cane","volume":"6","author":"Guglielmini C","year":"1997","unstructured":"Guglielmini C, Pietra M, Boari A, Famigli-Bergamini P, Bernardini D, Cipone M. Esperienze cliniche sull\u2019utilizzo della mexiletine nel trattamento delle aritmie ventricolari nel cane. Veterinaria. 1997;6:19-24."},{"issue":"3","key":"ref15","series-title":"Drugs","first-page":"161","article-title":"Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias","volume":"17","author":"Chew CY","year":"1979","unstructured":"Chew CY, Collett J, Singh BN. Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias. Drugs. 1979;17(3):161-181. doi:10.2165\/00003495-197917030-00003"},{"issue":"2","key":"ref16","series-title":"Arch Intern Med","first-page":"381","article-title":"Mexiletine: long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias","volume":"150","author":"Kerin NZ","year":"1990","unstructured":"Kerin NZ, Aragon E, Marinescu G, Faitel K, Frumin H, Rubenfire M. Mexiletine: long-term efficacy and side effects in patients with chronic drug-resistant potentially lethal ventricular arrhythmias. Arch Intern Med. 1990;150(2):381-384. doi:10.1001\/archinte.1990.00390140095021"},{"issue":"5","key":"ref17","series-title":"Clin Cardiol","first-page":"349","article-title":"Mexiletine: pharmacology and therapeutic use","volume":"13","author":"Manolis AS","year":"1990","unstructured":"Manolis AS, Deering TF, Cameron J, Estes NA III. Mexiletine: pharmacology and therapeutic use. Clin Cardiol. 1990;13(5):349-359. doi:10.1002\/clc.4960130509"},{"issue":"3","key":"ref18","series-title":"Drugs","first-page":"374","article-title":"Mexiletine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias","volume":"40","author":"Monk JP","year":"1990","unstructured":"Monk JP, Brogden RN. Mexiletine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs. 1990;40(3):374-411. doi:10.2165\/00003495-199040030-00005"},{"key":"ref19","series-title":"Curr Protoc Pharmacol","article-title":"Overview of drug product development","author":"Narayan P","unstructured":"Narayan P. Overview of drug product development. Curr Protoc Pharmacol. Published online December 1, 2011. doi:10.1002\/0471141755.ph0703s55"},{"issue":"6","key":"ref20","series-title":"Animals (Basel)","first-page":"1645","article-title":"Lorenz plot analysis in dogs with sinus rhythm and tachyarrhythmias","volume":"11","author":"Romito G","year":"2021","unstructured":"Romito G, Guglielmini C, Poser H, Baron Toaldo M. Lorenz plot analysis in dogs with sinus rhythm and tachyarrhythmias. Animals (Basel). 2021;11(6):1645. doi:10.3390\/ani11061645"},{"key":"ref21","series-title":"J Vet Cardiol","first-page":"36","article-title":"Myocardial injury in dogs: a retrospective analysis on etiological, echocardiographic, electrocardiographic, therapeutic, and outcome findings in 102 cases","volume":"53","author":"Romito G","year":"2024","unstructured":"Romito G, Palatini L, Sabetti MC, Cipone M. Myocardial injury in dogs: a retrospective analysis on etiological, echocardiographic, electrocardiographic, therapeutic, and outcome findings in 102 cases. J Vet Cardiol. 2024;53:36-51. doi:10.1016\/j.jvc.2024.03.004"},{"issue":"4","key":"ref22","series-title":"J Am Vet Med Assoc","first-page":"538","article-title":"Evaluation of spontaneous variability in the frequency of ventricular arrhythmias in Boxers with arrhythmogenic right ventricular cardiomyopathy","volume":"224","author":"Spier AW","year":"2004","unstructured":"Spier AW, Meurs KM. Evaluation of spontaneous variability in the frequency of ventricular arrhythmias in Boxers with arrhythmogenic right ventricular cardiomyopathy. J Am Vet Med Assoc. 2004;224(4):538-541. doi:10.2460\/javma.2004.224.538"},{"issue":"2","key":"ref23","series-title":"J Vet Intern Med","first-page":"415","article-title":"Digoxin and mexiletine sensitivity in a Collie with the MDR1 mutation","volume":"20","author":"Henik RA","year":"2006","unstructured":"Henik RA, Kellum HB, Bentjen SA, Mealey KL. Digoxin and mexiletine sensitivity in a Collie with the MDR1 mutation. J Vet Intern Med. 2006;20(2):415-417. doi:10.1111\/j.1939-1676.2006.tb02878.x"},{"key":"ref24","series-title":"Kirk\u2019s Current Veterinary Therapy. Vol 15","first-page":"762","article-title":"Drugs for treatment of heart failure in dogs","author":"Bonagura JD","year":"2014","unstructured":"Bonagura JD, Keene BW. Drugs for treatment of heart failure in dogs. In: Bonagura JD, Twedt DC, eds. Kirk\u2019s Current Veterinary Therapy. Vol 15. Elsevier Saunders; 2014:762-772."},{"key":"ref25","series-title":"Kirk\u2019s Current Veterinary Therapy. Vol 15","first-page":"801","article-title":"Arrhythmogenic right ventricular cardiomyopathy","author":"Meurs KM","year":"2014","unstructured":"Meurs KM. Arrhythmogenic right ventricular cardiomyopathy. In: Bonagura JD, Twedt DC, eds. Kirk\u2019s Current Veterinary Therapy. Vol 15. Elsevier Saunders; 2014:801-804."},{"issue":"6","key":"ref26","series-title":"Clin Res Cardiol","first-page":"791","article-title":"Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias","volume":"113","author":"Alhourani N","year":"2024","unstructured":"Alhourani N, Wolfes J, K\u00f6nemann H,  Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias. Clin Res Cardiol. 2024;113(6):791-800. doi:10.1007\/s00392-024-02383-9"},{"issue":"3","key":"ref27","series-title":"J Am Vet Med Assoc","first-page":"342","article-title":"ECG of the Month: ventricular arrhythmia in a dog","volume":"243","author":"Sanders RA","year":"2013","unstructured":"Sanders RA, Kurosawa TA. ECG of the Month: ventricular arrhythmia in a dog. J Am Vet Med Assoc. 2013;243(3):342-344. doi:10.2460\/javma.243.3.342"},{"issue":"2","key":"ref28","series-title":"J Cardiovasc Pharmacol","first-page":"199","article-title":"Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator","volume":"62","author":"Gao D","year":"2013","unstructured":"Gao D, Van Herendael H, Alshengeiti L,  Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator. J Cardiovasc Pharmacol. 2013;62(2):199-204. doi:10.1097\/FJC.0b013e31829651fe"},{"issue":"2","key":"ref29","series-title":"Chest","first-page":"358","article-title":"Efficacy of oral mexiletine therapy at a 12-h dosage interval","volume":"97","author":"Steen SN","year":"1990","unstructured":"Steen SN, Hughes EM, Sharon G, MacGregor TR. Efficacy of oral mexiletine therapy at a 12-h dosage interval. Chest. 1990;97(2):358-363. doi:10.1378\/chest.97.2.358"},{"issue":"1","key":"ref30","series-title":"Pacing Clin Electrophysiol","first-page":"90","article-title":"Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy","volume":"37","author":"Ermakov S","year":"2014","unstructured":"Ermakov S, Hoffmayer KS, Gerstenfeld EP, Scheinman MM. Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy. Pacing Clin Electrophysiol. 2014;37(1):90-94. doi:10.1111\/pace.12250"},{"issue":"14","key":"ref31","series-title":"Am J Cardiol","first-page":"18I","article-title":"Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia","volume":"62","author":"Patt MV","year":"1988","unstructured":"Patt MV, Grossbard CL, Graboys TB, Lown B. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia. Am J Cardiol. 1988;62(14):18I-21I. doi:10.1016\/0002-9149(88)91343-4"},{"issue":"6 pt 1","key":"ref32","series-title":"Am Heart J","first-page":"788","article-title":"Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia","volume":"100","author":"Waleffe A","year":"1980","unstructured":"Waleffe A, Mary-Rabine L, Legrand V, Demoulin JC, Kulbertus HE. Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia. Am Heart J. 1980;100(6 pt 1):788-793. doi:10.1016\/0002-8703(80)90057-5"},{"issue":"3","key":"ref33","series-title":"J Cardiovasc Pharmacol","first-page":"286","article-title":"A comparison of the cellular electrophysiology of mexiletine and sotalol, singly and combined, in canine Purkinje fibers","volume":"12","author":"Berman ND","year":"1988","unstructured":"Berman ND, Loukides JE. A comparison of the cellular electrophysiology of mexiletine and sotalol, singly and combined, in canine Purkinje fibers. J Cardiovasc Pharmacol. 1988;12(3):286-292. doi:10.1097\/00005344-198809000-00005"},{"issue":"4","key":"ref34","series-title":"J Cardiovasc Pharmacol","first-page":"557","article-title":"Sotalol and mexiletine: combination of rate-dependent electrophysiological effects","volume":"16","author":"Varr\u00f3 A","year":"1990","unstructured":"Varr\u00f3 A, Lathrop DA. Sotalol and mexiletine: combination of rate-dependent electrophysiological effects. J Cardiovasc Pharmacol. 1990;16(4):557-567. doi:10.1097\/00005344-199010000-00006"},{"issue":"12","key":"ref35","series-title":"Clin Cardiol","first-page":"951","article-title":"Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia","volume":"14","author":"Ravid S","year":"1991","unstructured":"Ravid S, Lampert S, Graboys TB. Effect of the combination of low-dose mexiletine and metoprolol on ventricular arrhythmia. Clin Cardiol. 1991;14(12):951-955. doi:10.1002\/clc.4960141204"},{"issue":"1","key":"ref36","series-title":"Digestion","first-page":"43","article-title":"Sodium channel blockers alter slow-wave frequency of the rat stomach in vivo","volume":"48","author":"Bielefeldt K","year":"1991","unstructured":"Bielefeldt K, Bass P. Sodium channel blockers alter slow-wave frequency of the rat stomach in vivo. Digestion. 1991;48(1):43-50. doi:10.1159\/000200662"},{"issue":"1","key":"ref37","series-title":"Gastroenterology","first-page":"178","article-title":"Sodium current in human jejunal circular smooth muscle cells","volume":"122","author":"Holm AN","year":"2002","unstructured":"Holm AN, Rich A, Miller SM,  Sodium current in human jejunal circular smooth muscle cells. Gastroenterology. 2002;122(1):178-187. doi:10.1053\/gast.2002.30346"},{"issue":"9","key":"ref38","series-title":"Cureus","first-page":"e1646","article-title":"Gastrointestinal side effects of antiarrhythmic medications: a review of current literature","volume":"9","author":"Amjad W","year":"2017","unstructured":"Amjad W, Qureshi W, Farooq A,  Gastrointestinal side effects of antiarrhythmic medications: a review of current literature. Cureus. 2017;9(9):e1646. doi:10.7759\/cureus.1646"},{"issue":"1","key":"ref39","series-title":"Eur J Pharmacol","first-page":"9","article-title":"Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle","volume":"74","author":"Courtney KR","year":"1981","unstructured":"Courtney KR. Comparative actions of mexiletine on sodium channels in nerve, skeletal and cardiac muscle. Eur J Pharmacol. 1981;74(1):9-18. doi:10.1016\/0014-2999(81)90317-4"},{"issue":"1","key":"ref40","series-title":"Neuroscience","first-page":"27","article-title":"Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter","volume":"71","author":"Stys PK","year":"1996","unstructured":"Stys PK, Lesiuk H. Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter. Neuroscience. 1996;71(1):27-36. doi:10.1016\/0306-4522(95)00430-0"},{"issue":"1-2","key":"ref41","series-title":"Mol Cell Biochem","first-page":"125","article-title":"Neuroprotective effect of mexiletine in the central nervous system of diabetic rats","volume":"286","author":"Ates O","year":"2006","unstructured":"Ates O, Cayli SR, Altinoz E,  Neuroprotective effect of mexiletine in the central nervous system of diabetic rats. Mol Cell Biochem. 2006;286(1-2):125-131. doi:10.1007\/s11010-005-9102-6"},{"issue":"3","key":"ref42","series-title":"Mol Pharmacol","first-page":"236","article-title":"Mexiletine block of voltage-gated sodium channels: isoform- and state-dependent drug-pore interactions","volume":"95","author":"Nakagawa H","year":"2019","unstructured":"Nakagawa H, Munakata T, Sunami A. Mexiletine block of voltage-gated sodium channels: isoform- and state-dependent drug-pore interactions. Mol Pharmacol. 2019;95(3):236-244. doi:10.1124\/mol.118.114025"},{"issue":"6","key":"ref43","series-title":"J Toxicol Clin Toxicol","first-page":"731","article-title":"Mexiletine overdose producing status epilepticus without cardiovascular abnormalities","volume":"32","author":"Nelson LS","year":"1994","unstructured":"Nelson LS, Hoffman RS. Mexiletine overdose producing status epilepticus without cardiovascular abnormalities. J Toxicol Clin Toxicol. 1994;32(6):731-736. doi:10.3109\/15563659409017980"},{"issue":"1","key":"ref44","series-title":"J Cardiovasc Pharmacol","first-page":"43","article-title":"Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction","volume":"1","author":"Campbell RW","year":"1979","unstructured":"Campbell RW, Achuff SC, Pottage A, Murray A, Prescott LF, Julian DG. Mexiletine in the prophylaxis of ventricular arrhythmias during acute myocardial infarction. J Cardiovasc Pharmacol. 1979;1(1):43-52. doi:10.1097\/00005344-197901000-00005"},{"issue":"8","key":"ref45","series-title":"Eur Heart J","first-page":"675","article-title":"Antiarrhythmic efficacy of combined intravenous and oral mexiletine in acute myocardial infarction: a double blind placebo-controlled study","volume":"5","author":"Halinen MO","year":"1984","unstructured":"Halinen MO, Pentik\u00e4inen PJ, Helin MJ, Rehnberg S. Antiarrhythmic efficacy of combined intravenous and oral mexiletine in acute myocardial infarction: a double blind placebo-controlled study. Eur Heart J. 1984;5(8):675-683. doi:10.1093\/oxfordjournals.eurheartj.a061725"},{"issue":"6","key":"ref46","series-title":"J Am Coll Cardiol","first-page":"1148","article-title":"International mexiletine and placebo antiarrhythmic coronary trial, I: report on arrhythmia and other findings","volume":"4","author":"Impact Research Group","year":"1984","unstructured":"Impact Research Group. International mexiletine and placebo antiarrhythmic coronary trial, I: report on arrhythmia and other findings. J Am Coll Cardiol. 1984;4(6):1148-1163. doi:10.1016\/S0735-1097(84)80133-3"},{"issue":"4","key":"ref47","series-title":"G Ital Cardiol","first-page":"488","article-title":"La mexiletina nel trattamento delle aritmie ventricolari croniche refrattarie","volume":"11","author":"Bellocci F","year":"1981","unstructured":"Bellocci F, Ansalone G, Scabbia E,  La mexiletina nel trattamento delle aritmie ventricolari croniche refrattarie. G Ital Cardiol. 1981;11(4):488-497."},{"issue":"3","key":"ref48","series-title":"Indian Heart J","first-page":"142","article-title":"Mexiletine in ventricular arrhythmias\u2014an assessment by 24 hours Holter monitoring","volume":"36","author":"Gambhir DS","year":"1984","unstructured":"Gambhir DS, Khalilullah M, Bahl VK. Mexiletine in ventricular arrhythmias\u2014an assessment by 24 hours Holter monitoring. Indian Heart J. 1984;36(3):142-146."},{"issue":"5","key":"ref49","series-title":"G Ital Cardiol","first-page":"417","article-title":"Efficacia antiaritmica dell\u2019associazione amiodarone-mexiletina nel trattamento di aritmie ventricolari complesse resistenti","volume":"16","author":"Purcaro A","year":"1986","unstructured":"Purcaro A, Massacci C, Curzi G,  Efficacia antiaritmica dell\u2019associazione amiodarone-mexiletina nel trattamento di aritmie ventricolari complesse resistenti. G Ital Cardiol. 1986;16(5):417-426."},{"issue":"3","key":"ref50","series-title":"Clin Ther","first-page":"392","article-title":"Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography","volume":"11","author":"Hwang YS","year":"1989","unstructured":"Hwang YS, Wang JL. Efficacy of mexiletine in ventricular arrhythmias among patients in Taiwan: assessment by 24-hour Holter electrocardiography. Clin Ther. 1989;11(3):392-397."}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/263\/11\/javma.25.02.0088.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/263\/11\/javma.25.02.0088.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/263\/11\/javma.25.02.0088.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:34:20Z","timestamp":1761064460000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/263\/11\/javma.25.02.0088.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":50,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.2460\/javma.25.02.0088","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]}}}